Background: A universal newborn hepatitis B (HBV) vaccination program was introduced in the Northern Territory of Australia in 1990, followed by a school-based catch-up program. We evaluated the prevalence of hepatitis B infection in birthing women up to 20 years after vaccination and compared this to women born before the programs commenced. Methods: A cohort of birthing mothers was defined from Northern Territory public hospital birth records between 2005 and 2010 and linked to laboratory confirmed notifications of chronic HBV, based principally on a record of hepatitis B surface antigen detection. Prevalence of HBV was compared between women born before or after implementation of the newborn and catch-up vaccination programs. Findings: A...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...
Background: A universal newborn hepatitis B (HBV) vaccination program was introduced in the Northern...
Background/Aims: To evaluate the long-term effect of infant and childhood hepatitis B (HBV) vaccinat...
© 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved.Objectives: To evaluate the ef...
Background A higher prevalence of chronic hepatitis B (CHB) has been reported in Aboriginal and Torr...
BACKGROUND: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
Abstract Background Chronic hepatitis B is a public health concern in Aboriginal communities in the ...
In November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program ...
BACKGROUND: Aboriginal and Torres Strait Islander people are disproportionately affected by hepatiti...
Routine antenatal screening for chronic hepatitis B (HBV) in countries with high migrant populations...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
Vertical transmission from mother-to-child is an important mode of hepatitis B virus (HBV) infection...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...
Background: A universal newborn hepatitis B (HBV) vaccination program was introduced in the Northern...
Background/Aims: To evaluate the long-term effect of infant and childhood hepatitis B (HBV) vaccinat...
© 2017 AMPCo Pty Ltd. Produced with Elsevier B.V. All rights reserved.Objectives: To evaluate the ef...
Background A higher prevalence of chronic hepatitis B (CHB) has been reported in Aboriginal and Torr...
BACKGROUND: In Australia, higher rates of chronic hepatitis B (HBsAg) have been reported among Abori...
BACKGROUND: Indigenous populations globally are disproportionately affected by chronic hepatitis B v...
Abstract Background Chronic hepatitis B is a public health concern in Aboriginal communities in the ...
In November 2005, hepatitis A vaccine was funded under the Australian National Immunisation Program ...
BACKGROUND: Aboriginal and Torres Strait Islander people are disproportionately affected by hepatiti...
Routine antenatal screening for chronic hepatitis B (HBV) in countries with high migrant populations...
The objective of this study was to determine long-term immunity to hepatitis B virus (HBV) in a coho...
Vertical transmission from mother-to-child is an important mode of hepatitis B virus (HBV) infection...
OBJECTIVE: To quantify the disparity in incidence of hepatitis B between indigenous and non-indigeno...
From August 1989 to may 1993, extensive studies on the epidemiology of hepatitis B virus (HBV) infec...
The Australian National Hepatitis B Strategy 2010-13 outlines five priority areas for developing a c...